GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM (CAS:PRO) » Definitions » Research & Development

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM (CAS:PRO) Research & Development : MAD0.0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2007. Start your Free Trial

What is PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Research & Development for the six months ended in Jun. 2024 was MAD0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 was MAD0.0 Mil.

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Research & Development Historical Data

The historical data trend for PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Research & Development Chart

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial - - - - -

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Semi-Annual Data
Jun15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was MAD0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM  (CAS:PRO) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Research & Development Related Terms

Thank you for viewing the detailed overview of PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM (CAS:PRO) » Definitions » Research & Development
Comparable Companies
ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA SHSE:688506 BOM:500087 TSE:4507 SZSE:000538 UTHR NSE:TORNTPHARM BOM:543904 BOM:500124 BOM:500257 NBIX
Traded in Other Exchanges
N/A
Address
Rue N 7, ZI du Sahel, BP 96/97, Berrechid, Had Soualem, MAR, 26400
Website
http://www.promopharm.co.ma
PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM is engaged in production, marketing, import and export of pharmaceuticals, parapharmaceuticals, dermopharmaceuticals and cosmetics.